Over the past decade, hyperhomocysteinemia and MTHFR C677T polymorphism have been regarded solely as potential contributors to the greater risk of thrombosis in IBD [14,15,30-32]. The gene discussed is MTHFR; the disease is hyperhomocysteinemia.